A study of fraction of exhaled nitric oxide levels as a diagnostic marker in patients with bronchial asthma

U. B. Nayak, N. V. Morakhia, V. K. Acharya, L. Srinivas

Research output: Contribution to journalArticle

Abstract

Aim: To compare the fraction of exhaled nitric oxide (FENO) levels in patients with and without bronchial asthma and correlate the FENO level with steroid therapy and severity of bronchial asthma.Study design: A cross-sectional case control study of 55 cases of bronchial asthma and 45 controls.Materials and methods: Fifty-five cases of bronchial asthma and 45 controls with identical demographic characteristics, having respiratory diseases other than asthma but not on steroids were studied and compared. Computerised spirometry studies and FENO levels measurement by chemiluminiscence NO-analyser was performed in both the groups and compared. The data was analysed using SPSS software.Results: The mean FENO levels were significantly higher in asthmatics [16.5 parts per billion (ppb)] as compared to non asthmatics (5.5 ppb). The sensitivity of FENO in making a diagnosis of asthma was 72% and the specificity 88%. The mean FENO levels were significantly higher in both steroid treated cases (15.7 ppb) and steroid naïve cases (41.5 ppb) as compared to controls (14.4 ppb). The mean FENO level increases as the severity of asthma increases in both steroid treated (mild-6.3, moderate-15.1, severe-18.8 ppb) and steroid naïve cases (mild-11.9, moderate-20.7, severe 28.9 ppb). The FENO levels were lower in steroid treated cases as compared to steroid naïve cases, however the difference was not statistically significant. Conclusion: FENO levels are elevated in bronchial asthma and have a sensitivity of 72% and specificity of 88% as a diagnostic marker. FENO levels significantly correlate with the severity of asthma and the levels reduce with steroid therapy.

Original languageEnglish
Pages (from-to)123-127
Number of pages5
JournalJournal, Indian Academy of Clinical Medicine
Volume14
Issue number2
Publication statusPublished - 15-07-2013
Externally publishedYes

Fingerprint

Nitric Oxide
Asthma
Steroids
Spirometry
Case-Control Studies
Software
Demography
Sensitivity and Specificity
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Nayak, U. B. ; Morakhia, N. V. ; Acharya, V. K. ; Srinivas, L. / A study of fraction of exhaled nitric oxide levels as a diagnostic marker in patients with bronchial asthma. In: Journal, Indian Academy of Clinical Medicine. 2013 ; Vol. 14, No. 2. pp. 123-127.
@article{e1dc7a46bbd14a54b63e3d8d2d61e367,
title = "A study of fraction of exhaled nitric oxide levels as a diagnostic marker in patients with bronchial asthma",
abstract = "Aim: To compare the fraction of exhaled nitric oxide (FENO) levels in patients with and without bronchial asthma and correlate the FENO level with steroid therapy and severity of bronchial asthma.Study design: A cross-sectional case control study of 55 cases of bronchial asthma and 45 controls.Materials and methods: Fifty-five cases of bronchial asthma and 45 controls with identical demographic characteristics, having respiratory diseases other than asthma but not on steroids were studied and compared. Computerised spirometry studies and FENO levels measurement by chemiluminiscence NO-analyser was performed in both the groups and compared. The data was analysed using SPSS software.Results: The mean FENO levels were significantly higher in asthmatics [16.5 parts per billion (ppb)] as compared to non asthmatics (5.5 ppb). The sensitivity of FENO in making a diagnosis of asthma was 72{\%} and the specificity 88{\%}. The mean FENO levels were significantly higher in both steroid treated cases (15.7 ppb) and steroid na{\"i}ve cases (41.5 ppb) as compared to controls (14.4 ppb). The mean FENO level increases as the severity of asthma increases in both steroid treated (mild-6.3, moderate-15.1, severe-18.8 ppb) and steroid na{\"i}ve cases (mild-11.9, moderate-20.7, severe 28.9 ppb). The FENO levels were lower in steroid treated cases as compared to steroid na{\"i}ve cases, however the difference was not statistically significant. Conclusion: FENO levels are elevated in bronchial asthma and have a sensitivity of 72{\%} and specificity of 88{\%} as a diagnostic marker. FENO levels significantly correlate with the severity of asthma and the levels reduce with steroid therapy.",
author = "Nayak, {U. B.} and Morakhia, {N. V.} and Acharya, {V. K.} and L. Srinivas",
year = "2013",
month = "7",
day = "15",
language = "English",
volume = "14",
pages = "123--127",
journal = "Journal, Indian Academy of Clinical Medicine",
issn = "0972-3560",
publisher = "Indian Academy of Clinical Medicine",
number = "2",

}

A study of fraction of exhaled nitric oxide levels as a diagnostic marker in patients with bronchial asthma. / Nayak, U. B.; Morakhia, N. V.; Acharya, V. K.; Srinivas, L.

In: Journal, Indian Academy of Clinical Medicine, Vol. 14, No. 2, 15.07.2013, p. 123-127.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A study of fraction of exhaled nitric oxide levels as a diagnostic marker in patients with bronchial asthma

AU - Nayak, U. B.

AU - Morakhia, N. V.

AU - Acharya, V. K.

AU - Srinivas, L.

PY - 2013/7/15

Y1 - 2013/7/15

N2 - Aim: To compare the fraction of exhaled nitric oxide (FENO) levels in patients with and without bronchial asthma and correlate the FENO level with steroid therapy and severity of bronchial asthma.Study design: A cross-sectional case control study of 55 cases of bronchial asthma and 45 controls.Materials and methods: Fifty-five cases of bronchial asthma and 45 controls with identical demographic characteristics, having respiratory diseases other than asthma but not on steroids were studied and compared. Computerised spirometry studies and FENO levels measurement by chemiluminiscence NO-analyser was performed in both the groups and compared. The data was analysed using SPSS software.Results: The mean FENO levels were significantly higher in asthmatics [16.5 parts per billion (ppb)] as compared to non asthmatics (5.5 ppb). The sensitivity of FENO in making a diagnosis of asthma was 72% and the specificity 88%. The mean FENO levels were significantly higher in both steroid treated cases (15.7 ppb) and steroid naïve cases (41.5 ppb) as compared to controls (14.4 ppb). The mean FENO level increases as the severity of asthma increases in both steroid treated (mild-6.3, moderate-15.1, severe-18.8 ppb) and steroid naïve cases (mild-11.9, moderate-20.7, severe 28.9 ppb). The FENO levels were lower in steroid treated cases as compared to steroid naïve cases, however the difference was not statistically significant. Conclusion: FENO levels are elevated in bronchial asthma and have a sensitivity of 72% and specificity of 88% as a diagnostic marker. FENO levels significantly correlate with the severity of asthma and the levels reduce with steroid therapy.

AB - Aim: To compare the fraction of exhaled nitric oxide (FENO) levels in patients with and without bronchial asthma and correlate the FENO level with steroid therapy and severity of bronchial asthma.Study design: A cross-sectional case control study of 55 cases of bronchial asthma and 45 controls.Materials and methods: Fifty-five cases of bronchial asthma and 45 controls with identical demographic characteristics, having respiratory diseases other than asthma but not on steroids were studied and compared. Computerised spirometry studies and FENO levels measurement by chemiluminiscence NO-analyser was performed in both the groups and compared. The data was analysed using SPSS software.Results: The mean FENO levels were significantly higher in asthmatics [16.5 parts per billion (ppb)] as compared to non asthmatics (5.5 ppb). The sensitivity of FENO in making a diagnosis of asthma was 72% and the specificity 88%. The mean FENO levels were significantly higher in both steroid treated cases (15.7 ppb) and steroid naïve cases (41.5 ppb) as compared to controls (14.4 ppb). The mean FENO level increases as the severity of asthma increases in both steroid treated (mild-6.3, moderate-15.1, severe-18.8 ppb) and steroid naïve cases (mild-11.9, moderate-20.7, severe 28.9 ppb). The FENO levels were lower in steroid treated cases as compared to steroid naïve cases, however the difference was not statistically significant. Conclusion: FENO levels are elevated in bronchial asthma and have a sensitivity of 72% and specificity of 88% as a diagnostic marker. FENO levels significantly correlate with the severity of asthma and the levels reduce with steroid therapy.

UR - http://www.scopus.com/inward/record.url?scp=84879905287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879905287&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 123

EP - 127

JO - Journal, Indian Academy of Clinical Medicine

JF - Journal, Indian Academy of Clinical Medicine

SN - 0972-3560

IS - 2

ER -